Skip to main content

Find Clinical Trials

Home
Conditions
Pancreatic Neoplasms

Clinical trial condition

Pancreatic Neoplasms

Explore clinical trials studying Pancreatic Neoplasms. Study availability and eligibility vary by location and protocol.

142 public trials 40 recruiting studies

Refine in advanced search Browse all conditions

Pancreatic Neoplasms trial results

Completed

An Analysis of Presentation and Outcome Following Treatment of Pancreatic Endocrine Neoplasms

NCT02400996

Conditions: Adenoma, Adenoma, Islet Cell, Digestive System Diseases, +10 more
Locations: Not specified

View Trial Details

Completed

Whole Body 111In-exendin-4 Imaging Study in Insulinoma Patients

NCT00937079

Conditions: Adenoma, Adenoma, Islet Cell, Digestive System Diseases, +15 more
Locations: University Hospital Basel, Institute of Nuclear Medicine Basel, Canton of Basel-City, Switzerland

View Trial Details

Completed

Sorafenib Tosylate in Treating Patients With Progressive Metastatic Neuroendocrine Tumors

NCT00131911

Conditions: Adenocarcinoma, Adenoma, Adenoma, Islet Cell, +28 more
Locations: Mayo Clinic Rochester, Minnesota, United States

View Trial Details

Completed

Sorafenib in Combination With RAD001 in Patients With Advanced Neuroendocrine Tumors

NCT00942682

Conditions: Adenocarcinoma, Adenoma, Adenoma, Islet Cell, +18 more
Locations: Dana-Farber Cancer Institute Boston, Massachusetts, United States

View Trial Details

Completed

Capecitabine and Streptozocin With or Without Cisplatin in Treating Patients With Unresectable or Metastatic Neuroendocrine Tumors

NCT00602082

Conditions: Adenocarcinoma, Adenoma, Adenoma, Islet Cell, +22 more
Locations: Basildon University Hospital Basildon, England, United Kingdom

Addenbrooke's Hospital Cambridge, England, United Kingdom

Cookridge Hospital Leeds, England, United Kingdom

Leicester Royal Infirmary Leicester, England, United Kingdom

View all 17 locations

View Trial Details

Completed

Thalidomide in Treating Patients With Metastatic Neuroendocrine Tumors

NCT00027638

Conditions: Adenocarcinoma, Adenoma, Adenoma, Islet Cell, +30 more
Locations: Memorial Sloan-Kettering Cancer Center New York, United States

View Trial Details

Completed

Gefitinib in Treating Patients With Progressive Metastatic Neuroendocrine Tumors

NCT00075439

Conditions: Adenocarcinoma, Adenoma, Adenoma, Islet Cell, +26 more
Locations: Mayo Clinic Rochester, Minnesota, United States

View Trial Details

Completed

Yttrium Y 90 SMT 487 in Treating Patients With Refractory or Recurrent Cancer

NCT00006368

Conditions: Adenocarcinoma, Adenoma, Adenoma, Islet Cell, +105 more
Locations: H. Lee Moffitt Cancer Center and Research Institute Tampa, Florida, United States

View Trial Details

Completed

PS-341 in Treating Patients With Metastatic Neuroendocrine Tumors

NCT00017199

Conditions: Adenocarcinoma, Adenoma, Adenoma, Islet Cell, +22 more
Locations: University of Chicago Cancer Research Center Chicago, Illinois, United States

Arthur G. James Cancer Hospital - Ohio State University Columbus, Ohio, United States

View Trial Details

Completed

Phase II Study of Sunitinib Malate Following Hepatic Artery Embolization

NCT00434109

Conditions: Adenocarcinoma, Adenoma, Adenoma, Islet Cell, +22 more
Locations: H. Lee Moffitt Cancer Center & Research Institute Tampa, Florida, United States

View Trial Details